Metabolome analysis of erythrocytes from patients with chronic hepatitis C reveals the etiology of ribavirin-induced hemolysis

Tetsuru Karasawa, Takafumi Saito, Yoshiyuki Ueno, Masahiro Sugimoto, Tomoyoshi Soga

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Ribavirin is one of the major agents used in combination therapy with interferon for chronic hepatitis C, but is often associated with hemolytic anemia as a serious adverse event. Employing metabolome analysis, we demonstrated that the concentrations of intermediate metabolites produced by glycolysis and the pentose phosphate cycle in patients' erythrocytes were significantly decreased after administration of ribavirin. Our findings suggest that hemolysis associated with ribavirin is triggered by an energy crisis and consequent oxidative stress, thus having implications for the prevention of such hemolysis.

Original languageEnglish
Pages (from-to)1575-1577
Number of pages3
JournalInternational Journal of Medical Sciences
Volume10
Issue number11
DOIs
Publication statusPublished - 2013 Sep 9

Fingerprint

Metabolome
Ribavirin
Chronic Hepatitis C
Hemolysis
Erythrocytes
Pentoses
Hemolytic Anemia
Glycolysis
Interferons
Oxidative Stress
Phosphates
Therapeutics

Keywords

  • Anemia
  • Glycolysis
  • HCV
  • Metabolome
  • Pentose phosphate cycle
  • Ribavirin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metabolome analysis of erythrocytes from patients with chronic hepatitis C reveals the etiology of ribavirin-induced hemolysis. / Karasawa, Tetsuru; Saito, Takafumi; Ueno, Yoshiyuki; Sugimoto, Masahiro; Soga, Tomoyoshi.

In: International Journal of Medical Sciences, Vol. 10, No. 11, 09.09.2013, p. 1575-1577.

Research output: Contribution to journalArticle

Karasawa, Tetsuru ; Saito, Takafumi ; Ueno, Yoshiyuki ; Sugimoto, Masahiro ; Soga, Tomoyoshi. / Metabolome analysis of erythrocytes from patients with chronic hepatitis C reveals the etiology of ribavirin-induced hemolysis. In: International Journal of Medical Sciences. 2013 ; Vol. 10, No. 11. pp. 1575-1577.
@article{a3996fa3742e4619bc525f2ae443cdcf,
title = "Metabolome analysis of erythrocytes from patients with chronic hepatitis C reveals the etiology of ribavirin-induced hemolysis",
abstract = "Ribavirin is one of the major agents used in combination therapy with interferon for chronic hepatitis C, but is often associated with hemolytic anemia as a serious adverse event. Employing metabolome analysis, we demonstrated that the concentrations of intermediate metabolites produced by glycolysis and the pentose phosphate cycle in patients' erythrocytes were significantly decreased after administration of ribavirin. Our findings suggest that hemolysis associated with ribavirin is triggered by an energy crisis and consequent oxidative stress, thus having implications for the prevention of such hemolysis.",
keywords = "Anemia, Glycolysis, HCV, Metabolome, Pentose phosphate cycle, Ribavirin",
author = "Tetsuru Karasawa and Takafumi Saito and Yoshiyuki Ueno and Masahiro Sugimoto and Tomoyoshi Soga",
year = "2013",
month = "9",
day = "9",
doi = "10.7150/ijms.6436",
language = "English",
volume = "10",
pages = "1575--1577",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "11",

}

TY - JOUR

T1 - Metabolome analysis of erythrocytes from patients with chronic hepatitis C reveals the etiology of ribavirin-induced hemolysis

AU - Karasawa, Tetsuru

AU - Saito, Takafumi

AU - Ueno, Yoshiyuki

AU - Sugimoto, Masahiro

AU - Soga, Tomoyoshi

PY - 2013/9/9

Y1 - 2013/9/9

N2 - Ribavirin is one of the major agents used in combination therapy with interferon for chronic hepatitis C, but is often associated with hemolytic anemia as a serious adverse event. Employing metabolome analysis, we demonstrated that the concentrations of intermediate metabolites produced by glycolysis and the pentose phosphate cycle in patients' erythrocytes were significantly decreased after administration of ribavirin. Our findings suggest that hemolysis associated with ribavirin is triggered by an energy crisis and consequent oxidative stress, thus having implications for the prevention of such hemolysis.

AB - Ribavirin is one of the major agents used in combination therapy with interferon for chronic hepatitis C, but is often associated with hemolytic anemia as a serious adverse event. Employing metabolome analysis, we demonstrated that the concentrations of intermediate metabolites produced by glycolysis and the pentose phosphate cycle in patients' erythrocytes were significantly decreased after administration of ribavirin. Our findings suggest that hemolysis associated with ribavirin is triggered by an energy crisis and consequent oxidative stress, thus having implications for the prevention of such hemolysis.

KW - Anemia

KW - Glycolysis

KW - HCV

KW - Metabolome

KW - Pentose phosphate cycle

KW - Ribavirin

UR - http://www.scopus.com/inward/record.url?scp=84883862332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883862332&partnerID=8YFLogxK

U2 - 10.7150/ijms.6436

DO - 10.7150/ijms.6436

M3 - Article

VL - 10

SP - 1575

EP - 1577

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 11

ER -